SLS Prakiraan wutah bathi resik saben saham ing taun iki SELLAS Life Sciences Group Inc.
SELLAS Life Sciences develops advanced peptide immunotherapies to combat oncology, actively investing in the GPS platform. The annual earnings per share trajectory, illustrated by this chart on GURU.Markets, contains the mark 18.20, indicating the level of EPS dynamics. However, the narrow pipeline focus creates binary risks, and the retention of scientific staff is based solely on faith in the success of the developments.
Rincian metrik keuangan lan pasar sellaslifesciences.com (SLS)
- nilai saham lan prakiraan konsensus rega:
- data kapitalisasi pasar:
- data nilai buku modal saham:
- indikator beban utang lan likuiditas:
Utang marang Ekuitas SELLAS Life Sciences|SLS - Utang jangka dawa marang modal|Utang jangka cendhak marang modal SELLAS Life Sciences Group|SLS - Utang perusahaan|Utang-utang marang aset resik SELLAS Life Sciences|SLS - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan SELLAS Life Sciences|Likuiditas cepet sellaslifesciences.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
SLS - Bathi resik|Prakiraan bathi perusahaan SELLAS Life Sciences|SLS - Pangali P/E|Rasio rega marang bathi sing dikarepake SELLAS Life Sciences Group|SLS - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan SELLAS Life Sciences|SLS - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajroning taun lumaku SELLAS Life Sciences|SLS - Bathi saben saham sajrone rolas wulan pungkasan|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan sellaslifesciences.com|SLS - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep SELLAS Life Sciences
Analisis dhasar perusahaan:SLS - SELLAS Life Sciences Group Inc.
For the biopharmaceutical sector, SELLAS Life Sciences (SLS) utilizes measured YoY EPS growth as an indicator of the company's ability to convert large-scale investments in the GPS platform into actual shareholder value. This metric's price action reflects the percentage change in net income per share relative to the previous year, allowing investors to assess capital management efficiency against the backdrop of intensive R&D expenditures.
Pesaing wigati
Kacepetan wutah bathi saben saham ing taun lumaku BeiGene Ltd. (ONC)|Wutah bathi saben saham ing taun lumaku Halozyme Inc.|Revolution Medicines Corp (RVMD) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi ing taun lumaku AAPG|CGON - Kacepetan wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku UroGen Pharma URGN|Bicara Therapeutics Inc - Wutah bathi saben saham ing taun lumaku|PSNL - Wutah bathi saben saham ing taun lumaku|ERAS: Wutah bathi saben saham ing taun lumaku|DCTH: Wutah bathi ing taun lumaku|ymabs.com (YMAB) - Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun lumaku Aura Biosciences|Candel (CADL) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi resik saben saham ing taun iki ARAY (Accuray Inc.)|ACTU (Actuate Therapeutics Inc) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Citius Oncology, Inc. CTOR|TuHURA Biosciences Inc. - Wutah bathi saben saham ing taun lumaku|Protara Therapeutics, Inc. - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun iki Fate Therapeutics Inc FATE|WHWK: Wutah bathi ing taun lumaku|Dinamika bathi saben saham ing taun lumaku TCRX (TScan Therapeutics, Inc.)|CSBR (Champions Oncology Inc) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku XBiotech USA XBIT|Wutah bathi resik saben saham ing taun iki CVM (CEL-SCI Corporation)|OSTX (OS Therapies Inc.) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Radiopharm Theranostics RADX|Prakiraan wutah bathi resik saben saham ing taun iki Artiva Biotherapeutics Inc. (ARTV)|Adlai Nortye Limited - Wutah bathi ing taun lumaku|verupharma.com (VERU) - Wutah bathi resik saben saham ing taun iki|TPST: Wutah bathi ing taun lumaku|XLO - Prakiraan wutah bathi resik saben saham ing taun iki|RENB (Renovaro Biosciences) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Mural Bio MURA|Wutah bathi saben saham ing taun lumaku Kairos Pharma Ltd (KAPA)|onkuretherapeutics.com - Wutah bathi saben saham ing taun iki|Wutah bathi ing taun lumaku GDTC (CytoMed Therapeutics Limited)|CRIS - Wutah bathi resik saben saham ing taun iki|Apollomics Corp - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Tharimmune Corporation|advanbiomed.com (ADVB) - Wutah bathi saben saham ing taun lumaku|GNPX - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku Calidi Biotherapeutics Inc.|sunshinebiopharma.com (SBFM) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku Xenetic Biosciences (XBIO)|Wutah bathi saben saham ing taun lumaku SLRX (Salarius Pharma)|Wutah bathi saben saham ing taun lumaku Purple Biotech PPBT|Prakiraan wutah bathi resik saben saham ing taun iki American Oncology Network Inc (AONC)|BeiGene - Wutah bathi ing taun lumaku|Checkpoint Therapeutics Inc. (CKPT) - Wutah bathi resik saben saham ing taun iki|ELEV: Wutah bathi ing taun lumaku|iCAD (ICAD) - Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun lumaku Ikena Oncology Inc.|Wutah bathi saben saham ing taun iki NTBL (notablelabs.com)|Wutah bathi ing taun lumaku VIRX|Wutah bathi resik saben saham ing taun iki MorphoSys Inc MOR|Wutah bathi ing taun lumaku NAYA (NAYA Bio)|Ascentage (AAPGV) - Kacepetan wutah bathi saben saham ing taun lumaku
